Literature DB >> 27400900

Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".

Yassine Bouatou1, Myriam El Biali1, Caroline Flora Samer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27400900     DOI: 10.1161/CIRCULATIONAHA.116.022034

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  2 in total

1.  Comparative Effectiveness of Rivaroxaban, Apixaban, and Warfarin in Atrial Fibrillation Patients With Polypharmacy.

Authors:  Amgad Mentias; Eric Heller; Mary Vaughan Sarrazin
Journal:  Stroke       Date:  2020-06-10       Impact factor: 7.914

2.  Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect.

Authors:  Kuntheavy Ing Lorenzini; Youssef Daali; Pierre Fontana; Jules Desmeules; Caroline Samer
Journal:  Front Pharmacol       Date:  2016-12-19       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.